{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Dosing Patterns In Treatment of Disabling Spasticity With Intrathecal Baclofen

Activity Steps

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Select the results of the study of patterns of ITB use that provide insight about dosing of patients with various central nervous system disorders.
  2. Choose the results of the study that address complications of this treatment for reducing disabling spasticity.
  3. Recognize the evidence about the use of ITB that helped inform the study of dosing patterns for patients receiving this treatment for reducing disabling spasticity.

Learning Outcomes

Nurses will demonstrate knowledge of a study describing and analyzing dosing patterns for patients with intrathecal baclofen (ITB) treatment over time and identifying possible subgroups demonstrating diversity in patterns by achieving a minimum score of 70% on the outcomes-based posttest.
Price: $12.50

Credits:

  • ANCC 2.0 CH
  • DC - BON 2.0 CH
  • FL - BON 2.0 CH
  • GA - BON 2.0 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.







Test Code: RNJ1121A
Published: Nov/Dec 2021
Expires: 12/6/2024
Required Passing Score: 8/10 (80%)
Authors: Stina Gunnarsson, MSc, RN; Dag Lemming, PhD, MD; Siw Alehagen, PhD, RN; Shala Berntsson, PhD,MD; Per Ertzgaard, PhD, MD; Kersti Samuelsson, PhD, OT